A decades-old, relatively unknown private biotech focused on iron deficiency is buying a commercial-stage oncology company nestled in North Carolina.
Holbæk, Denmark-headquartered Pharmacosmos will acquire …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Regeneron may soon be staring down another competitor to its blockbuster Eylea. Sandoz’s biosimilar candidate aflibercept proved equivalent to the brand-name eye drug in a
WASHINGTON – Powerful House lawmakers from both parties are skeptical of the Food and Drug Administration’s pitch to start collecting fees from e-cigarette companies, similar
Hardman & Co Research Hardman & Co Investor Forum Research on Custodian Property Income REIT (CREI): Good momentum, modest risk 20-Nov-2024 / 13:55 GMT/BST The